Hepatologist @michiganliver @vaannarbor; #cirrhosis; encephalopathy; frailty; quality improvement; father; husband. #livertwitter Co-EIC of @HepCommJournal
Ann Arbor, MI
Joined September 2011
- Tweets15.7K
- Following657
- Followers43.3K
- Likes32.3K
Elliot Tapper retweeted
Co-Editors @ebtapper and Carmen Chak-Lui Wong highlight October's @HepCommJournal, featuring liver decompensation, acute kidney injury in alcohol-associated hepatitis, pediatric PSC, ferroptosis, and more!
Watch below and explore the issue: journals.lww.com/hepcomm/toc…
youtu.be/QniIrUn-Sfo
Elliot Tapper retweeted
Fangirling over @umichmedicine Hepatology & LTx, home of the world’s best liver docs!
Honored to be invited by the great Dr. Anna Lok for the Sheila Sherlock visiting professorship. #GoBlue (❤️ @zingermans)
@ebtapper @NikMazumder_MD @pummy92 @RobertFontanaMD @HPB_Txp_Surg
Elliot Tapper retweeted
📑 Seladelpar in patients with #PBC and compensated #cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies‼️
#OpenAccess #LiverX
journals.lww.com/hepcomm/ful…
Elliot Tapper retweeted
📑#MetALD is emerging as a major 🌎 liver disease phenotype‼️
⭐️10-20% of people with hepatic steatosis meet MetALD criteria❕
⚠️Metabolic dysfunction ➕ alcohol 🍻➡️ increased risks of fibrosis progression, cirrhosis, & HCC❕
#OpenAccess
journals.lww.com/hepcomm/ful…
Elliot Tapper retweeted
🏆 Your #HepMadness2026 bracket could win you AASLD swag!
Prizes include an AASLD swag bag with an AASLD water bottle, liver socks, and much more!
⏰ Submit your bracket by October 31 for a chance to win! 👇
tourneytopia.com/aasld/hepma…
Elliot Tapper retweeted
📑 L-Taurine for #Fatigue in Decompensated Cirrhosis⁉️
❎ Negative trial overall
⭐️ BUT, patients without anemia🩸 had a large ⬇️ in fatigue 😴, while those with anemia did not❕
#OpenAccess #LiverX
journals.lww.com/hepcomm/ful…
Elliot Tapper retweeted
📑 Low serum pseudocholinesterase levels are associated with mortality in patients with #HCC‼️
#OpenAccess #LiverX
journals.lww.com/hepcomm/ful…
Elliot Tapper retweeted
📑 Group-based #telehealth 💻behavioral interventions for chronic liver disease‼️
A 14-week group telehealth intervention achieved 84% retention & 91% session attendance❕
⭐️Improvement trends in stress, coping, relaxation 🧘, & sleep hygiene 😴
journals.lww.com/hepcomm/ful…
Elliot Tapper retweeted
Have you signed up for #HepMadness2026 yet? 🏆
16 hepatology themes go head-to-head!
A great learning opportunity with recent articles handpicked from @LTxJournal & @HepCommJournal, summarized by team @LiverFellow.
Open to ALL! Make your picks by Oct 31! 🔥
Sign up & FAQs here 🔗 aasld.org/liver-fellow-n…
🥇 to be announced at #TLM2026
@AASLDtweets @AASLDFoundation @AASLDPresident @ebtapper @jlouissaint89 @WAleyadeh @SarahKhan9894
Elliot Tapper retweeted
1/6 🚨 THE BRACKET IS LIVE 🚨
HepMadness 2026 starts NOW.
16 themes. 4 rounds. 1 champion 🏆
The best hepatology and transplant science of the year, going head to head. Who survives?
#HepMadness2026
aasld.org/liver-fellow-netwo…
Elliot Tapper retweeted
📑 Autoimmune liver diseases in Latin America 🌎: Current landscape and challenges‼️
#OpenAccess #LiverX #PBC #AIH
journals.lww.com/hepcomm/ful…
Elliot Tapper retweeted
It's finally here. HepMADNESS 2026 is LIIIIIIVE! Submit your predictions and may the best hepatocurious person win!
@LiverFellow @AASLDtweets @ebtapper @jlouissaint89 #LiverTwitter #TLM2026
1/6 🚨 THE BRACKET IS LIVE 🚨
HepMadness 2026 starts NOW.
16 themes. 4 rounds. 1 champion 🏆
The best hepatology and transplant science of the year, going head to head. Who survives?
#HepMadness2026
aasld.org/liver-fellow-netwo…
Elliot Tapper retweeted
Check out the bracket! Make your picks by October 31! #HepMadness2026 #LiverTwitter @LiverFellow @AASLDtweets @ebtapper @jlouissaint89
Elliot Tapper retweeted
1/6 🚨 THE BRACKET IS LIVE 🚨
HepMadness 2026 starts NOW.
16 themes. 4 rounds. 1 champion 🏆
The best hepatology and transplant science of the year, going head to head. Who survives?
#HepMadness2026
aasld.org/liver-fellow-netwo…
Elliot Tapper retweeted
🆕 Introducing AASLD EXPOs!
AASLD has published its first-ever Expert-Based Practice Opinion #EXPO. The inaugural EXPO: #LiverBiopsy, published in @HEP_Journal, delivers timely, expert-informed guidance on the evolving role of liver biopsy.
🔗 Learn more: bit.ly/4dH2I9l
@elizabeth_verna @DouglasAdlerMD @LizRandLiverDoc @ebtapper
Elliot Tapper retweeted
🎉 A historic milestone for AASLD journals!
@HEP_Journal has achieved its highest-ever #ImpactFactor of 21.3, reinforcing its position as a global leader in liver research and scientific discovery.
The milestones don't stop there! @HepCommJournal also reached a record-high Impact Factor of 6.2.
These achievements reflect the exceptional contributions of our authors, reviewers, and editorial teams and AASLD's continued commitment to advancing liver science and improving patient care worldwide.
Read the full announcement: bit.ly/4jndxRJ
Elliot Tapper retweeted
Thank you just so much - I am incredibly honored & grateful ❤️
Counting down the seconds until @AmCollegeGastro next year 🙌
@AmCollegeGastro @umfoodoc
Elliot Tapper retweeted
📑 Integrating behavioral health into hepatology improves #AUD care‼️🍺
⬆️ Any AUD treatment: 80% vs 28%
⬆️ Psychotherapy: 76% vs 24%
⬆️ Pharmacotherapy: 41% vs 12% 💊
#OpenAccess #LiverX
@ponnivp
journals.lww.com/hepcomm/ful…
Elliot Tapper retweeted
🔥 HOT TOPIC
📘 @HepCommJournal
Nearly 1 in 5 youth with biopsy-confirmed #MASLD began drinking during adolescence or early adulthood.
In the largest longitudinal study of its kind, researchers followed more than 1,100 youth and found that alcohol use was associated with faster increases in liver enzymes, reinforcing the importance of routine alcohol screening and developmentally tailored counseling in pediatric MASLD care.
Read the article: bit.ly/4rPDaN0
